NCT05823298Completed
Translation And Psychometric Testing Of The Turkish Version Of Fugl-Meyer Assessment
Translation And Psychometric Evaluation Of The Turkish Fugl-Meyer Assessment For Upper And Lower Extremities
Source: ClinicalTrials.gov · Last updated 7 May 2026
Brief summary (registry, in English)
The aim of this methodological study is to adapt the Fugl-Meyer assessment to Turkish culture and to test its validity and reliability in acute phase stroke patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 80 (actual)
- First submitted
- 9 Apr 2023
- Start date
- 15 Dec 2023
- Primary completion date
- 15 Aug 2024
- Lead sponsor
- Istanbul University - Cerrahpasa
- Diseases
- Stroke
- NCT number
- NCT05823298
What you commit to
- Study type: Observational
- Participants enrolled: 80
- From 15 Dec 2023 to the primary completion date, 15 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Visual or hearing impairment
- Global aphasia or psychiatric disorder affecting daily life and participation
- Any unstable medical condition affecting participation
Other
- Upper or lower extremity amputation
- MMSE score ≤21
Who the study is looking for
- Age ≥18 years
- Hemiparesis or hemiplegia due to ischemic or hemorrhagic stroke within the previous 8 - weeks
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| İstinye University Liv Hospital Stroke Center Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.